Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Zhongjian Xie, Yun Chen, Sirel Gurbuz, Bin Zhang, Yujie Li, Fan Bai & Yu Chen. (2019) Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy. Clinical Interventions in Aging 14, pages 959-968.
Read now
Read now
Satoshi Soen, Saeko Fujiwara, Ryoichi Takayanagi, Kenta Kajimoto, Mika Tsujimoto, Shuichi Kimura, Masayo Sato, John H. Krege & Hiroyuki Enomoto. (2017) Real-world effectiveness of daily teriparatide in Japanese patients with osteoporosis at high risk for fracture: final results from the 24-month Japan Fracture Observational Study (JFOS). Current Medical Research and Opinion 33:11, pages 2049-2056.
Read now
Read now
Satoshi Soen, Saeko Fujiwara, Ryoichi Takayanagi, Masayo Sato, Mika Tsujimoto, Takanori Yamamoto, Hiroyuki Enomoto & John H. Krege. (2015) Japan Fracture Observational Study (JFOS): patient characteristics and interim data on the use of daily teriparatide in Japanese patients with osteoporosis. Current Medical Research and Opinion 31:9, pages 1771-1779.
Read now
Read now
Andrea Sikon & Pelin Batur. (2010) Profile of teriparatide in the management of postmenopausal osteoporosis. International Journal of Women's Health 2, pages 37-44.
Read now
Read now
Articles from other publishers (45)
G. Porcu, A. Biffi, R. Ronco, G. Adami, R. Alvaro, R. Bogini, A. P. Caputi, B. Frediani, D. Gatti, S. Gonnelli, G. Iolascon, A. Lenzi, S. Leone, R. Michieli, S. Migliaccio, T. Nicoletti, M. Paoletta, A. Pennini, E. Piccirilli, M. Rossini, U. Tarantino, L. Cianferotti, M. L. Brandi & G. Corrao. (2023) Refracture following vertebral fragility fracture when bone fragility is not recognized: summarizing findings from comparator arms of randomized clinical trials. Journal of Endocrinological Investigation.
Crossref
Crossref
Mina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, Jeanett Friis Rohde, Anja Ussing, Sabrina Mai Nielsen, Robin Christensen, Jean-Jacques Body, Maria Luisa Brandi, Adolfo Diez-Perez, Peyman Hadji, Muhammad Kassim Javaid, Willem Frederik Lems, Xavier Nogues, Christian Roux, Salvatore Minisola, Andreas Kurth, Thierry Thomas, Daniel Prieto-Alhambra, Serge Livio Ferrari, Bente Langdahl & Bo Abrahamsen. (2023) Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ, pages e068033.
Crossref
Crossref
Takeshi Mochizuki, Koichiro Yano, Katsunori Ikari & Ken Okazaki. (2023) Comparison of different parameters between daily and twice-weekly teriparatide in postmenopausal women with severe osteoporosis. Journal of Bone and Mineral Metabolism 41:2, pages 220-226.
Crossref
Crossref
Chelsea Ayers, Devan KansagaraBrittany LazurRongwei FuAmy Kwon & Curtis Harrod. (2023) Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians. Annals of Internal Medicine 176:2, pages 182-195.
Crossref
Crossref
John H Krege, Alicia W Gilsenan, John L Komacko & Nicole Kellier‐Steele. (2022) Teriparatide and Osteosarcoma Risk: History, Science, Elimination of Boxed Warning, and Other Label Updates. JBMR Plus 6:9.
Crossref
Crossref
Tasuku Mashiba, Ryuji Fujihara, Shingo Yoshitake, Ken Iwata, Ryoko Takao-Kawabata & Tetsuji Yamamoto. 2022. Osteoporotic Fracture and Systemic Skeletal Disorders. Osteoporotic Fracture and Systemic Skeletal Disorders
361
376
.
Fernando Marin & Yanfei L. Ma. 2022. Osteoporotic Fracture and Systemic Skeletal Disorders. Osteoporotic Fracture and Systemic Skeletal Disorders
339
359
.
Katherine N. Haseltine, Tariq Chukir, Pinar J. Smith, Justin T. Jacob, John P. Bilezikian & Azeez Farooki. (2021) Bone Mineral Density: Clinical Relevance and Quantitative Assessment. Journal of Nuclear Medicine 62:4, pages 446-454.
Crossref
Crossref
O. V. Yakushevskaya. (2021) Potential protective effect of zoledronic acid when switching from long-term therapy of osteoporosis with denosumab. Meditsinskiy sovet = Medical Council:21, pages 185-191.
Crossref
Crossref
Gaia Tabacco & John P. Bilezikian. (2019) Osteoanabolic and dual action drugs. British Journal of Clinical Pharmacology 85:6, pages 1084-1094.
Crossref
Crossref
Hiroshi Kawaguchi. (2019) Basic of Osteoporosis and the Topics骨粗鬆症の基礎と最近の話題. The Japanese Journal of Rehabilitation Medicine 56:5, pages 349-360.
Crossref
Crossref
Naohisa Miyakoshi, Masashi Fujii, Yuji Kasukawa & Yoichi Shimada. (2018) Impact of vitamin C on teriparatide treatment in the improvement of bone mineral density, strength, and quality in vitamin C-deficient rats. Journal of Bone and Mineral Metabolism 37:3, pages 411-418.
Crossref
Crossref
Ryuji Fujihara, Tasuku Mashiba, Shingo Yoshitake, Satoshi Komatsubara, Ken Iwata, Ryoko Takao-Kawabata & Tetsuji Yamamoto. (2019) Weekly teriparatide treatment increases vertebral body strength by improving cortical shell architecture in ovariectomized cynomolgus monkeys. Bone 121, pages 80-88.
Crossref
Crossref
Stuart Silverman, Bente L. Langdahl, Saeko Fujiwara, Ken Saag, Nicola Napoli, Satoshi Soen, Hiroyuki Enomoto, Thomas E. Melby, Damon P. Disch, Fernando Marin & John H. Krege. (2018) Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational Studies. Calcified Tissue International 104:2, pages 193-200.
Crossref
Crossref
Eleftherios P Paschalis, John H Krege, Sonja Gamsjaeger, Erik F Eriksen, David B Burr, Damon P Disch, Jan J Stepan, Astrid Fahrleitner-Pammer, Klaus Klaushofer, Fernando Marin & Imre Pavo. (2018) Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray-Based Bone Assessment Techniques. Journal of Bone and Mineral Research 33:12, pages 2230-2235.
Crossref
Crossref
. (2018) 当院における椎体骨折保存加療後の新規椎体骨折の発生について. Orthopedics & Traumatology 67:4, pages 722-725.
Crossref
Crossref
Adriana Medina Orjuela, Óscar Rosero Olarte, Pedro Nel Rueda Plata, Fabio Sánchez Escobar, Monique Chalem Choueka, Miguel Ángel González Reyes, Alejandro Román González, Alexandra Terront Lozano, Amanda Páez Talero, Camilo Rueda Belt, Carlos Alfonso Builes Barrera, Carlos Augusto Pérez Niño, Daniel G. Fernández Ávila, David Vásquez Awad, Deyanira González Devia, Edgar Pinilla Pabón, Eduardo Antonio Reina Valdivieso, Esdras Martín Vásquez Mejía, Francisco Iván Vargas Grajales, Francisco Linares Restrepo, Geraldine Altamar Canales, Gustavo Adolfo Molina Uribe, Gustavo Adolfo Pineda Acero, Henry Mauricio Arenas Quintero, Jorge Augusto Vélez Patiño, José Fernando Molina Restrepo, Juan José Jaller Raad, Ricardo Londoño Gutiérrez, Adriana Medina Orjuela, Óscar Rosero Olarte, Pedro Nel Rueda Plata, Fabio Sánchez Escobar, Monique Chalem Choueka, Miguel Ángel González Reyes, Patricia Clark, Orlando Angulo Ceballos & Carlos Federico Molina Castaño. (2018) Second Colombian Consensus on the Management of Post-menopausal Osteoporosis: 2017 update. Revista Colombiana de Reumatología (English Edition) 25:3, pages 184-210.
Crossref
Crossref
Adriana Medina Orjuela, Óscar Rosero Olarte, Pedro Nel Rueda Plata, Fabio Sánchez Escobar, Monique Chalem Choueka, Miguel Ángel González Reyes, Alejandro Román González, Alexandra Terront Lozano, Amanda Páez Talero, Camilo Rueda Beltz, Carlos Alfonso Builes Barrera, Carlos Augusto Pérez Niño, Daniel G. Fernández Ávila, David Vásquez Awad, Deyanira González Devia, Edgar Pinilla Pabón, Eduardo Antonio Reina Valdivieso, Esdras Martín Vásquez Mejía, Francisco Iván Vargas Grajales, Francisco Linares Restrepo, Geraldine Altamar Canales, Gustavo Adolfo Molina Uribe, Gustavo Adolfo Pineda Acero, Henry Mauricio Arenas Quintero, Jorge Augusto Vélez Patiño, José Fernando Molina Restrepo, Juan José Jaller Raad & Ricardo Londoño Gutiérrez. (2018) II Consenso Colombiano para el Manejo de la Osteoporosis Posmenopáusica. Revista Colombiana de Reumatología 25:3, pages 184-210.
Crossref
Crossref
Sang-Min KimKyung-Chung KangJi Wan KimSeung-Jae LimMyung Hoon Hahn. (2017) Current Role and Application of Teriparatide in Fracture Healing of Osteoporotic Patients: A Systematic Review. Journal of Bone Metabolism 24:1, pages 65.
Crossref
Crossref
R. Lindsay, J. H. Krege, F. Marin, L. Jin & J. J. Stepan. (2016) Teriparatide for osteoporosis: importance of the full course. Osteoporosis International 27:8, pages 2395-2410.
Crossref
Crossref
Soledad Herrero & Yolanda Pico. (2016) Treatments for post-menopausal osteoporotic women, what’s new? How can we manage long-term treatment?. European Journal of Pharmacology 779, pages 8-21.
Crossref
Crossref
A A Volna, O B Ershova & L Ya Farba. (2015) THE RUSSIAN COUNCIL OF ExPERTS FOR IMPROVEMENT THE APPROACHES TO THE TREATMENT OF OSTEOPOROSIS. Osteoporosis and Bone Diseases 18:1, pages 38-40.
Crossref
Crossref
Takuji Matsumoto, Muneharu Ando & Shunji Sasaki. (2015) Effective treatment of delayed union of a lumbar vertebral fracture with daily administration of teriparatide in a patient with diffuse idiopathic skeletal hyperostosis. European Spine Journal 24:S4, pages 573-576.
Crossref
Crossref
Hiroshi Kawaguchi. (2015) Basic of Osteoporosis and the Topics. Spinal Surgery 29:3, pages 259-266.
Crossref
Crossref
Naohisa Miyakoshi, Akira Horikawa & Yoichi Shimada. (2015) Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture with Once-Weekly Teriparatide. Case Reports in Orthopedics 2015, pages 1-3.
Crossref
Crossref
Chad L. Deal & Abby G. Abelson. 2015. Rheumatology. Rheumatology
1663
1673
.
J.F. Chen, K. H. Yang, Z.L. Zhang, H.C. Chang, Y. Chen, H. Sowa & S. Gürbüz. (2014) A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia. Osteoporosis International 26:1, pages 11-28.
Crossref
Crossref
T. Sugimoto, T. Nakamura, Y. Nakamura, Y. Isogai & M. Shiraki. (2014) Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada. Osteoporosis International 25:9, pages 2323-2324.
Crossref
Crossref
J. H. Krege, N. E. Lane, J. M. Harris & P. D. Miller. (2014) PINP as a biological response marker during teriparatide treatment for osteoporosis. Osteoporosis International 25:9, pages 2159-2171.
Crossref
Crossref
Yani Liu, Chunxiao Yang, Zhongfang Li, Jiali Zhou, Yongning Lv, Yu Zhang, Fandian Zeng & Shaojun Shi. (2014) Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Parathyroid Hormone (1–34) in Healthy Chinese Subjects. Clinical Therapeutics 36:6, pages 940-952.
Crossref
Crossref
R. Niimi, T. Kono, A. Nishihara, M. Hasegawa, A. Matsumine, T. Nakamura, T. Kono & A. Sudo. (2013) An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatide. Osteoporosis International 25:1, pages 377-384.
Crossref
Crossref
John E. Ziewacz, Darryl Lau, Sigurd H. Berven, Armed J. Awad & Praveen V. Mummaneni. 2014. Minimally Invasive Spinal Deformity Surgery. Minimally Invasive Spinal Deformity Surgery
123
133
.
Shuko Nojiri, Russel T. Burge, Jennifer A. Flynn, Shonda A. Foster & Hideaki Sowa. (2013) Osteoporosis and treatments in Japan: management for preventing subsequent fractures. Journal of Bone and Mineral Metabolism 31:4, pages 367-380.
Crossref
Crossref
Felicia Cosman, Tony M Keaveny, David Kopperdahl, Robert A Wermers, Xiaohai Wan, Kelly D Krohn & John H Krege. (2013) Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene. Journal of Bone and Mineral Research 28:6, pages 1328-1336.
Crossref
Crossref
Toshitaka Nakamura, Toshitsugu Sugimoto, Tetsuo Nakano, Hideaki Kishimoto, Masako Ito, Masao Fukunaga, Hiroshi Hagino, Teruki Sone, Hideki Yoshikawa, Yoshiki Nishizawa, Takuo Fujita & Masataka Shiraki. (2012) Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk. The Journal of Clinical Endocrinology & Metabolism 97:9, pages 3097-3106.
Crossref
Crossref
P. Hadji, J. R. Zanchetta, L. Russo, C. P. Recknor, K. G. Saag, F. E. McKiernan, S. L. Silverman, J. Alam, R. T. Burge, J. H. Krege, M. C. Lakshmanan, D. N. Masica, B. H. Mitlak & J. L. Stock. (2011) The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporosis International 23:8, pages 2141-2150.
Crossref
Crossref
Felicia Cosman, Bess Dawson-Hughes, Xiaohai Wan & John H. Krege. (2012) Changes in vitamin D metabolites during teriparatide treatment. Bone 50:6, pages 1368-1371.
Crossref
Crossref
Toshitaka Nakamura, Mika Tsujimoto, Etsuro Hamaya, Hideaki Sowa & Peiqi Chen. (2011) Consistency of fracture risk reduction in Japanese and Caucasian osteoporosis patients treated with teriparatide: a meta-analysis. Journal of Bone and Mineral Metabolism 30:3, pages 321-325.
Crossref
Crossref
Y. M. Kim, S. Demissie, H. K. Genant, X. Cheng, W. Yu, E. J. Samelson, D. P. Kiel & M. L. Bouxsein. (2011) Identification of prevalent vertebral fractures using CT lateral scout views: a comparison of semi-automated quantitative vertebral morphometry and radiologist semi-quantitative grading. Osteoporosis International 23:3, pages 1007-1016.
Crossref
Crossref
JH Krege & X Wan. (2012) Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis. Bone 50:1, pages 161-164.
Crossref
Crossref
Y. M. Kim, S. Demissie, R. Eisenberg, E. J. Samelson, D. P. Kiel & M. L. Bouxsein. (2011) Intra-and inter-reader reliability of semi-automated quantitative morphometry measurements and vertebral fracture assessment using lateral scout views from computed tomography. Osteoporosis International 22:10, pages 2677-2688.
Crossref
Crossref
Mika Tsujimoto, Peiqi Chen, Akimitsu Miyauchi, Hideaki Sowa & John H. Krege. (2011) PINP as an aid for monitoring patients treated with teriparatide. Bone 48:4, pages 798-803.
Crossref
Crossref
Chad L. Deal & Abby G. Abelson. 2011. Rheumatology. Rheumatology
1975
1988.e4
.
Marcy B. Bolster. (2010) Osteoporosis and Bone Health in Patients with Lung Disease. Clinics in Chest Medicine 31:3, pages 555-563.
Crossref
Crossref
Elizabeth File & Chad Deal. (2009) Clinical update on teriparatide. Current Rheumatology Reports 11:3, pages 169-176.
Crossref
Crossref